,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['congrat', 'breast', 'destinybreast04']
dear great choice inviting dr. lorusso to do this discussion. her multi-disease, drug development lens was refreshing and wonderful! dear pass on my warm congratulations since i can t congratulate her here on twitter. #asco22 #destinybreast04
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine